「the clinical」の検索結果
88件：81～85件目を表示
もしかして
-
tical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
tical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
g approval in Japan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 anta...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
g approval in Japan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 anta...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Research and Development System | Research & Development | SENJU Pharmaceutica
through a flexible concept without adhering to a conventional framework or stereotypes. Looking at the future and quickly developing safe drugs that are needed are our goals as well as our wishes. Me...
http://www.senju.co.jp/english/rd/about/